Next Article in Journal
The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies
Next Article in Special Issue
Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine
Previous Article in Journal
Development of an In Vitro Test Method to Replace an Animal-Based Potency Test for Pertactin Antigen in Multivalent Vaccines
Previous Article in Special Issue
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 276; https://doi.org/10.3390/vaccines11020276
Action Date Notes Link
article xml file uploaded 28 January 2023 03:06 CET Original file -
article xml uploaded. 28 January 2023 03:06 CET Update https://www.mdpi.com/2076-393X/11/2/276/xml
article pdf uploaded. 28 January 2023 03:06 CET Version of Record https://www.mdpi.com/2076-393X/11/2/276/pdf
article html file updated 28 January 2023 03:08 CET Original file -
article html file updated 1 March 2023 11:20 CET Update -
article html file updated 8 March 2023 02:52 CET Update https://www.mdpi.com/2076-393X/11/2/276/html
Back to TopTop